These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31550938)

  • 1. Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency.
    Pye A; Turner AM
    Expert Opin Investig Drugs; 2019 Oct; 28(10):891-902. PubMed ID: 31550938
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-antitrypsin deficiency.
    Bals R
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C; Reeves EP; McElvaney NG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 antitrypsin deficiency: current therapy and emerging targets.
    McElvaney OF; Fraughen DD; McElvaney OJ; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2023 Mar; 17(3):191-202. PubMed ID: 36896570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
    MacDonald JL; Johnson CE
    Am J Health Syst Pharm; 1995 Mar; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
    Mohanka M; Khemasuwan D; Stoller JK
    Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding and treating COPD related to α
    Henao MP; Craig TJ
    Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
    Greulich T
    COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
    Strnad P; San Martin J
    Expert Opin Investig Drugs; 2023; 32(7):571-581. PubMed ID: 37470509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency.
    Campos MA; Diaz AA
    Chest; 2018 May; 153(5):1240-1248. PubMed ID: 29175361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
    Hurley K; Reeves EP; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a survey of patients with alpha-1 antitrypsin deficiency.
    Strange C; Stoller JK; Sandhaus RA; Dickson R; Turino G
    Respiration; 2006; 73(2):185-90. PubMed ID: 16141711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.